SearcharxivSearch

arXiv subjects

Henning Hermjakob

Publications and source records attributed to Henning Hermjakob.

6 recordsLinked to original sources

APICURON: a reactive infrastructure for credit attribution across distributed research data ecosystems

Data-driven biology relies on structured knowledge generated by expert biocurators, yet this work remains largely unrecognized in traditional academic assessments. To bridge this gap, we present the updated APICURON platform, a credit-attribution infrastructure that formally acknowledges these scientific contributions. Rather than relying on delayed batch reporting, the system captures curation events as they happen and transforms them into verifiable units of work. This design allows independent resources to define and update their own recognition models while preserving the historical record of each contribution. For researchers, APICURON highlights recent activity alongside lifetime achievements and connects verified activities to persistent academic profiles via ORCID. APICURON has been successfully integrated across biological knowledgebases and data resources, demonstrating its application to diverse workflows. Extending beyond biodata resources, it also supports recognition of non-traditional research artefacts, including training materials and research software, without imposing a rigid definition of contribution.

cs.DB

EFECT: A Method to Quantify the Reproducibility of Stochastic Simulations

Reproducibility is a fundamental requirement for validating scientific claims in computational research. Stochastic computational models are widely used in fields such as systems biology, financial modeling and environmental sciences. However, achieving reproducibility in stochastic simulations remains challenging, as each run can produce different outcomes. Existing infrastructure and software tools do not address independent reproduction of simulation results. Without independent reproducibility, results and conclusions lack credibility, as it remains unclear whether observed findings reflect model behavior or are artifacts of stochastic variation or an underpowered study. To bridge this gap, we introduce the Empirical Characteristic Function Equality Convergence Test (EFECT), a data-driven method to quantify the reproducibility of stochastic simulation results. EFECT employs empirical characteristic functions to compare reported results with those independently generated by assessing distributional inequality, termed EFECT error. Additionally, we establish the EFECT convergence point, a quantitative metric for determining the required number of simulation runs to achieve an EFECT error value of a priori significance. EFECT is applicable to all bounded, real-valued outputs, regardless of the model type or simulation method that produced them. We tested EFECT with over 40 use cases to demonstrate its broad applicability and effectiveness. EFECT standardizes stochastic simulation reproducibility, establishing a workflow that guarantees reliable results, supporting a wide range of stakeholders, and thereby enhancing validation of stochastic simulation studies, across a model's lifecycle. To promote standardization, we are developing the open-source software library libSSR in multiple programming languages for easy integration of EFECT.

stat.ME

SBMLtoOdin and Menelmacar: Interactive visualisation of systems biology models for expert and non-expert audiences

Motivation: Computational models in biology can increase our understanding of biological systems, be used to answer research questions, and make predictions. Accessibility and reusability of computational models is limited and often restricted to experts in programming and mathematics. This is due to the need to implement entire models and solvers from the mathematical notation models are normally presented as. Implementation: Here, we present SBMLtoOdin, an R package that translates differential equation models in SBML format from the BioModels database into executable R code using the R package odin, allowing researchers to easily reuse models. We also present Menelmacar, a a web-based application that provides interactive visualisations of these models by solving their differential equations in the browser. This platform allows non-experts to simulate and investigate models using an easy-to-use web interface. Availability: SBMLtoOdin is published under open source Apache 2.0 licence at https://github.com/bacpop/SBMLtoOdin and can be installed as an R package. The code for the Menelmacar website is published under MIT License at https://github.com/bacpop/odinviewer, and the website can be found at https://biomodels.bacpop.org/.

q-bio.QM

Strategic priorities for transformative progress in advancing biology with proteomics and artificial intelligence

Artificial intelligence (AI) is transforming scientific research, including proteomics. Advances in mass spectrometry (MS)-based proteomics data quality, diversity, and scale, combined with groundbreaking AI techniques, are unlocking new challenges and opportunities in biological discovery. Here, we highlight key areas where AI is driving innovation, from data analysis to new biological insights. These include developing an AI-friendly ecosystem for proteomics data generation, sharing, and analysis; improving peptide and protein identification and quantification; characterizing protein-protein interactions and protein complexes; advancing spatial and perturbation proteomics; integrating multi-omics data; and ultimately enabling AI-empowered virtual cells.

q-bio.OT

Building an Ethical and Trustworthy Biomedical AI Ecosystem for the Translational and Clinical Integration of Foundational Models

Foundational Models (FMs) are gaining increasing attention in the biomedical AI ecosystem due to their ability to represent and contextualize multimodal biomedical data. These capabilities make FMs a valuable tool for a variety of tasks, including biomedical reasoning, hypothesis generation, and interpreting complex imaging data. In this review paper, we address the unique challenges associated with establishing an ethical and trustworthy biomedical AI ecosystem, with a particular focus on the development of FMs and their downstream applications. We explore strategies that can be implemented throughout the biomedical AI pipeline to effectively tackle these challenges, ensuring that these FMs are translated responsibly into clinical and translational settings. Additionally, we emphasize the importance of key stewardship and co-design principles that not only ensure robust regulation but also guarantee that the interests of all stakeholders, especially those involved in or affected by these clinical and translational applications are adequately represented. We aim to empower the biomedical AI community to harness these models responsibly and effectively. As we navigate this exciting frontier, our collective commitment to ethical stewardship, co-design, and responsible translation will be instrumental in ensuring that the evolution of FMs truly enhances patient care and medical decision making, ultimately leading to a more equitable and trustworthy biomedical AI ecosystem.

cs.CY

Large-scale generation of computational models from biochemical pathway maps

Background: Systems biology projects and omics technologies have led to a growing number of biochemical pathway reconstructions. However, mathematical models are still most often created de novo, based on reading the literature and processing pathway data manually. Results: To increase the efficiency with which such models can be created, we automatically generated mathematical models from pathway representations using a suite of freely available software. We produced models that combine data from KEGG PATHWAY, BioCarta, MetaCyc and SABIO-RK; According to the source data, three types of models are provided: kinetic, logical and constraint-based. All models are encoded using SBML Core and Qual packages, and available through BioModels Database. Each model contains the list of participants, the interactions, and the relevant mathematical constructs, but, in most cases, no meaningful parameter values. Most models are also available as easy to understand graphical SBGN maps. Conclusions: to date, the project has resulted in more than 140000 models freely available. We believe this resource can tremendously accelerate the development of mathematical models by providing initial starting points ready for parametrization.

q-bio.MN